Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
Abstract
Objectives: To characterise the association between type 2 diabetes mellitus (T2DM) subtypes (new-onset T2DM (NODM) or long-standing T2DM (LSDM)) and pancreatic cancer (PC) risk, to explore the direction of causation through Mendelian randomisation (MR) analysis and to assess the mediation role of body mass index (BMI).Design: Information about T2DM and related factors was collected from 2018 PC cases and 1540 controls from the PanGenEU (European Study into Digestive Illnesses and Genetics) study. A subset of PC cases and controls had glycated haemoglobin, C-peptide and genotype data. Multivariate logistic regression models were applied to derive ORs and 95% CIs. T2DM and PC-related single nucleotide polymorphism (SNP) were used as instrumental variables (IVs) in bidirectional MR analysis to test for two-way causal associations between PC, NODM and LSDM. Indirect and direct effects of the BMI-T2DM-PC association were further explored using mediation analysis.Results: T2DM was associated with an increased PC risk when compared with non-T2DM (OR=2.50; 95% CI: 2.05 to 3.05), the risk being greater for NODM (OR=6.39; 95% CI: 4.18 to 9.78) and insulin users (OR=3.69; 95% CI: 2.80 to 4.86). The causal association between T2DM (57-SNP IV) and PC was not statistically significant (ORLSDM=1.08, 95% CI: 0.86 to 1.29, ORNODM=1.06, 95% CI: 0.95 to 1.17). In contrast, there was a causal association between PC (40-SNP IV) and NODM (OR=2.85; 95% CI: 2.04 to 3.98), although genetic pleiotropy was present (MR-Egger: p value=0.03). Potential mediating effects of BMI (125-SNPs as IV), particularly in terms of weight loss, were evidenced on the NODM-PC association (indirect effect for BMI in previous years=0.55).Conclusion: Findings of this study do not support a causal effect of LSDM on PC, but suggest that PC causes NODM. The interplay between obesity, PC and T2DM is complex.Keywords
Funding Information
- Instituto de Salud Carlos III (PI0902102, PI11/01542, PI12/00815, PI12/01635, PI15/01573)
- Associazione Italiana Ricerca sul Cancro (12182)
- Cancer Focus Northern Ireland and Department for Employment and Learning
- Red Temática de Investigación Cooperativa en Cáncer (RD12/0036/0034, RD12/0036/0050, RD12/0036/0073)
- European Cooperation in Science and Technology (BM1204)
- Sixth Framework Programme (018771-MOLDIAG-PACA)
- ALF (SLL20130022)
- FP7 Health (256974-EPC-TM-Net, 259737-CANCERALIA)
This publication has 50 references indexed in Scilit:
- Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patientsNutrition, Metabolism and Cardiovascular Diseases, 2013
- Prevalence of Diabetes Mellitus in Pancreatic Cancer Compared to Common CancersPancreas, 2013
- Estimation of covariate effects in generalized linear mixed models with a misspecified distribution of random intercepts and slopesStatistics in Medicine, 2012
- Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset ageJournal of Gastroenterology, 2012
- Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studiesEuropean Journal of Cancer, 2011
- Weight Loss Precedes Cancer-Specific Symptoms in Pancreatic Cancer-Associated Diabetes MellitusPancreas, 2011
- Body Mass Index and Obesity- and Diabetes-Associated Genotypes and Risk for Pancreatic CancerCancer Epidemiology, Biomarkers & Prevention, 2011
- Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I dataCancer Causes & Control, 2011
- Mendelian Randomisation and Causal Inference in Observational EpidemiologyPLOS Medicine, 2008
- Flexible regression models with cubic splinesStatistics in Medicine, 1989